Fingerprint
Dive into the research topics of 'The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
Laura J. Klesse, Justin T. Jordan, Heather B. Radtke, Tena Rosser, Elizabeth Schorry, Nicole Ullrich, David Viskochil, Pamela Knight, Scott R. Plotkin, Kaleb Yohay
Research output: Contribution to journal › Article › peer-review
58
Scopus
citations